Wang Y, Wang R, Liu X, Liu M, Sun L, Pan X, et al. Chemotherapy-induced executioner caspase activation increases breast cancer malignancy through epigenetic de-repression of CDH12. Oncogenesis. 2023;12:34 pubmed publisher

Fan M, Gao J, Zhou L, Xue W, Wang Y, Chen J, et al. Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer. Acta Pharm Sin B. 2022;12:4407-4423 pubmed publisher

Sunahori K, Nagpal K, Hedrich C, Mizui M, Fitzgerald L, Tsokos G. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway . J Biol Chem. 2013;288:21936-44 pubmed publisher

Liu W, Chen Y, Cheng T, Lin S, Chang L. Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit ? and MAPK phosphatase-1 expression in human leukemia U937 cells. Cell Signal. 2013;25:1845-51 pubmed publisher

Liu W, Chen Y, Chang L. CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability. Int J Biochem Cell Biol. 2012;44:2212-22 pubmed publisher